SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001127602-17-021949
Filing Date
2017-06-21
Accepted
2017-06-21 14:19:57
Documents
1
Period of Report
2017-06-20

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT form4.html 4  
1 PRIMARY DOCUMENT form4.xml 4 3462
  Complete submission text file 0001127602-17-021949.txt   4872
Mailing Address 300 CONNELL DRIVE SUITE 4000 BERKELEY HEIGHTS NJ 07922
Business Address 300 CONNELL DRIVE SUITE 4000 BERKELEY HEIGHTS NJ 07922 800-208-3343
Edge Therapeutics, Inc. (Issuer) CIK: 0001472091 (see all company filings)

IRS No.: 264231384 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O NEW LEAF VENTURE PARTNERS 7 TIMES SQUARE - SUITE 3502 NEW YORK NY 10036
Business Address
Ratcliffe Liam (Reporting) CIK: 0001547100 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-37568 | Film No.: 17922649